Nasal swab for SARS-CoV-2 (Antigen Rapid Test)
(Liquid error (sections/product-template-tampone.liquid line 201): divided by 0% off)
Rapid HIGH PERFORMANCE test for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2. Provides an aid in identifying individuals suspected of an active COVID-19 infection by their healthcare provider within the first seven (7) days of the onset of symptoms.
PACK OF 25 SWABS.
RELATIVE SENSITIVITY: 97.1%
RELATIVE SPECIFICITY: 99.6%
THE PACKAGE CONTAINS:
• 25 Test Cassettes
• 1 Leaflet
• Extraction buffer solution
• 25 Eextraction tubes
• 1 Negative control swab
• 1 Positive control swab
• 25 Sterile nasal swabs in flocked cotton
Product Name: Flowflex SARS-CoV-2 Antigen Rapid Test
Catalog No: L031-11815 / L031-11825
Packaging: Kit of 25 tests
The SARS-CoV-2 Rapid Antigen Test is a lateral flow immunoassay for the qualitative detection of nucleocapsid protein antigen to SARS-CoV-2 directly on nasal swab specimens collected from individuals who may have contracted COVID-19 , by the respective healthcare provider within seven days of the onset of symptoms. The SARS-CoV-2 Rapid Antigen Test does not distinguish between SARS-CoV and SARS-CoV-2.
The results are used to identify the SARS-CoV-2 nucleocapsid antigen. This antigen is generally detectable in upper respiratory tract samples during the acute phase of the infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is required to determine the status of the infection. Positive results do not rule out bacterial infections or co-infections with other viruses. The agent detected may not be the definitive cause of the disease. Negative results, in patients with symptoms beyond seven days, should be treated as suspected and confirmed with a molecular test, if appropriate, for patient management. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole reference for patient treatment or management decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, medical history, and the presence of clinical signs and symptoms consistent with COVID-19.
The product is suitable for a qualitative test and an auxiliary diagnosis, therefore not a substitute for a diagnosis made with a professional in vitro diagnostic test.
The results rendered by the product must be considered only a clinical reference and not an exclusive basis for clinical diagnosis and treatment, which must in any case be carried out at the health facilities responsible for this.
For the technical specifications and limitations of use of the product, please refer to the package leaflet supplied with the product.
Pursuant to the New Guidelines of the Ministry of Health of 28/03/2013, relating to health advertising concerning medical devices, in vitro diagnostic medical devices and surgical medical devices, the user is advised that the information contained in the site is exclusively aimed at professional operators.
-View specifications and certifications
We deliver within EU only. For orders of € 69.00 or above there is no shipping charge.
Orders of less than € 69.00 shall incur a standard shipping charge depending on the different EU-ZONE ranging between € 6.50 and € 12.50.
If you’re looking to return or exchange your order for whatever reason, we're here to help! We offer free returns or exchanges within 14 days of purchase. You can return your product for a refund to the original payment method.
Please note the following exceptions to our return and refund policy:
- Discounted items are final and cannot be returned or exchanged
- Returned items must have tags still on and be returned in original product packaging
- Returned items must have no visible signs of wear or use